Saniclave 250
510(k) K180272
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK180272 | Date26 Jul 2018 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- FLE
- Device Class
- Class II
- Regulation
- 21 CFR Part 880.6880
- Advisory Committee
- General Hospital
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 27 Sep 2026
The Saniclave 250 is a steam sterilizer device classified as a General Hospital device under regulation number 880.6880. It is substantially equivalent to a predicate device and received traditional 510(k) clearance from the FDA under K180272.
The device is manufactured by Revolutionary Science and supplied as a non-sterile, reusable unit intended for use in general hospital settings. It is designed to sterilize standard medical instruments and hormone pelleting trocars, with no claims regarding sterility, single-use status, MRI safety, or storage conditions provided in the data.
Questions
AI-generated answers, 27 Sep 2026
What is the Saniclave 250 used for?
The Saniclave 250 is designed to sterilize standard medical instruments and hormone pelleting trocars in general hospital settings, as indicated by its classification under regulation number 880.6880 and its substantial equivalence to a predicate device.
Is the Saniclave 250 supplied sterile or non-sterile, and is it single-use or reusable?
The Saniclave 250 is supplied as a non-sterile, reusable unit, meaning it is not provided in a sterile condition and is intended for multiple uses after proper reprocessing, based on the device description.
What regulatory pathway was used for the Saniclave 250, and what is its K-number?
The Saniclave 250 received traditional 510(k) clearance from the FDA under K180272, indicating it was found substantially equivalent to a legally marketed predicate device through the traditional review process.